featured
Selective Internal Radiation Therapy vs Sorafenib in Hepatocellular Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
J. Clin. Oncol 2018 Mar 02;[EPub Ahead of Print], PKH Chow, M Gandhi, SB Tan, MW Khin, A Khasbazar, J Ong, SP Choo, PC Cheow, C Chotipanich, K Lim, LA Lesmana, TW Manuaba, BK Yoong, A Raj, CS Law, IHY Cua, RR Lobo, CSC Teh, YH Kim, YW Jong, HS Han, SH Bae, HK Yoon, RC Lee, CF Hung, CY Peng, PC Liang, A Bartlett, KYY Kok, CH Thng, AS Low, ASW Goh, KH Tay, RHG Lo, BKP Goh, DCE Ng, G Lekurwale, WM Liew, V Gebski, KSW Mak, KC SooFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.